V012-2525 Screening compound: N~1~-(4-fluorobenzyl)-2-{isobutyl[(4-methylphenyl)sulfonyl]amino}-N~1~-[(5-methyl-2-thienyl)methyl]acetamide

V012-2525 Screening compound: N~1~-(4-fluorobenzyl)-2-{isobutyl[(4-methylphenyl)sulfonyl]amino}-N~1~-[(5-methyl-2-thienyl)methyl]acetamide
V012-2525 Screening compound: N~1~-(4-fluorobenzyl)-2-{isobutyl[(4-methylphenyl)sulfonyl]amino}-N~1~-[(5-methyl-2-thienyl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V012-2525
N~1~-(4-fluorobenzyl)-2-{isobutyl[(4-methylphenyl)sulfonyl]amino}-N~1~-[(5-methyl-2-thienyl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V012-2525

Molecular Formula

C26H31FN2O3S2 (C26 H31 FN2 O3 S2)

Compound Name

N~1~-(4-fluorobenzyl)-2-{isobutyl[(4-methylphenyl)sulfonyl]amino}-N~1~-[(5-methyl-2-thienyl)methyl]acetamide

IUPAC name

N-[(4-fluorophenyl)methyl]-2-[N-(2-methylpropyl)4-methylbenzenesulfonamido]-N-[(5-methylthiophen-2-yl)methyl]acetamide

SMILES

CC(C)CN(CC(N(Cc1ccc(C)s1)Cc(cc1)ccc1F)=O)S(c1ccc(C)cc1)(=O)=O

InChI

InChI=1S/C26H31FN2O3S2/c1-19(2)15-29(34(31,32)25-13-5-20(3)6-14-25)18-26(30)28(17-24-12-7-21(4)33-24)16-22-8-10-23(27)11-9-22/h5-14,19H,15-18H2,1-4H3

InChI Key

UHWIRNGYNXSKCL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19761902

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

502.67

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.836

Distribution Coefficient, logD

5.836

Water Solubility, LogSw

-5.45

Polar Surface Area

48.316

Acid Dissociation Constant (pKa)

22.16

Base Dissociation Constant (pKb)

-3.97

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.62

V012-2525 in Drug Discovery

Included in Screening Libraries

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Endocrine
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V012-2525 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V012-2525?
Check Price and Availability of V012-2525, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V012-2525 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V012-2525
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V012-2525
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V012-2525 available by request